Lhasa Limited shared knowledge shared progress


Queens Award 2017 logo footer Click for full size image
Lhasa Recieves Second Queen's Award

Educational charity, Lhasa Limited, has received its second Queen’s Award for Enterprise in a visit from The Vice Lord-Lieutenant of West Yorkshire, Tim Hare.

19 September 2017
eTRANSAFE Click for full size image
Lhasa named as partner in €40 million drug safety project

40 Million EUR European project for new drug safety assessment and integrative data analysis research.

01 September 2017
AIPDE 256px Click for full size image
Consortium established to support ICH M7 compliance

Webinar to showcase data collaboration project

An industry workgroup comprising toxicologists, pharmaceutical companies and data experts plans to unveil the early results of a data sharing project designed to enhance the safety of drug substances and aid compliance with quality guidelines such as ICH M7.

31 July 2017
Queens Award 2017 logo footer Click for full size image
Lhasa Limited makes a second visit to Buckingham Palace

Representatives of Lhasa Limited have attended a reception at Buckingham Palace for the second year in a row.

12 July 2017
Vitic Nexus Logo Click for full size image
Vitic 2017.1.0 Data Released Today

New data for Vitic Nexus, Vitic Excipients and Vitic Intermediates has been released to members today.

03 May 2017
Sarah Nexus Click for full size image
Lhasa Limited receives second Queen’s Award for Enterprise as it unveils new CEO

Lhasa Limited, an educational charity which creates state-of-the-art in silico prediction and database systems for use in metabolism, toxicology and related sciences, has been awarded the Queen’s Award for Enterprise for the second year running.

21 April 2017
Business Masters Award 226px Click for full size image
Lhasa Scoops Innovation Award

Lhasa Limited, an educational charity which creates state-of-the-art in silico prediction and database systems for use in metabolism, toxicology and related sciences has been recognised for its innovative software.

12 April 2017
Shared Knowledge Shared Progress Click for full size image
Lhasa Limited and Optibrium Enter Research and Product Development Collaboration

Drug discovery software specialists combine expertise to extend studies into drug metabolism modelling

CAMBRIDGE and LEEDS, UK 11 April 2017– Optibrium™ and Lhasa Limited (Lhasa), developers of software for small molecule property prediction, design and optimisation, announced today they have formed a collaborative partnership to research next generation drug metabolism modelling. Results from the work will be used by both organisations in the development of future products with improved and extended metabolism prediction capabilities.

11 April 2017
eTOXsys logo 160px Click for full size image
New resource to improve early drug candidate safety assessment launched today

eTOXsys is released today, following a 7-year collaboration with key industry players

14 March 2017
Lhasa continues its collaboration with the US FDA

Lhasa is pleased to announce that it has signed an extension to its Research Collaboration Agreement (RCA) with the US Food and Drug Administration (FDA)

25 January 2017
Dave Watson 300px Click for full size image
A message from Lhasa CEO Dave Watson

Last week Dave Watson announced that he will be retiring from his position as CEO of Lhasa Limited. 

18 January 2017
Dave Watson, CEO of Lhasa Limited accepting the Queen's Award for Innovation award from HRH The Duke of Kent Click for full size image
A Royal Visit for Innovative Leeds Charity


His Royal Highness the Duke of Kent paid a special visit to an innovative Leeds-based charity, after it was awarded a Queen’s Award for Enterprise.

Lhasa Limited, which is based at Granary Wharf, is an educational charity which creates software that supports the pharmaceutical industry in bringing safe, effective and life enhancing medicines to market earlier.  Lhasa was recognised by the Queen’s Awards in the Innovation category, in acknowledgement of its work with 350 of its members which include the world’s leading pharmaceutical companies, such as AstraZeneca, GlaxoSmithKline and Pfizer.

16 November 2016
Lhasa Limited unveils new-look Carcinogenicity Database

Lhasa Limited, a not-for-profit organisation and educational charity that promotes public education through the development of computer-aided reasoning and information systems in chemistry and the related-sciences, today releases the Lhasa Carcinogenicity Database.


18 October 2016
American Flag Click for full size image
Lhasa Limited builds on its reputation for world class technical support by increasing its presence in the United States

Lhasa Limited, an educational charity and leading global supplier of knowledge based software and associated databases for use in toxicity, metabolism and the related sciences, today announces the expansion of its US based team of account managers.

04 October 2016

Contact Us

© 2017 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

QuestionPro supports sample survey questions such as multiple choice, drop-down menu, likert-scale, semantic differential, matrix, constant sum, drag-and-drop, slider-scale, net-promoter scale, and many more question types.